Utility of 5-ALA for resection of CNS tumours other than high-grade gliomas: a protocol for a systematic review

INTRODUCTION: 5-aminolevulinic acid (5-ALA) is a proagent developed for fluorescent-guided surgery for high-grade glioma patients associated with a significant increase in resection conferring survival. 5-ALA was shown to penetrate the blood–brain barrier accumulating in malignant glioma cells with...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomou, Georgios, Gharooni, Aref-Ali, Patel, Waqqas, Gillespie, Conor S, Gough, Melissa, Venkatesh, Ashwin, Poon, Michael T C, Wykes, Victoria, Price, Stephen John, Jenkinson, Michael D, Watts, Colin, Plaha, Puneet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315896/
https://www.ncbi.nlm.nih.gov/pubmed/35868820
http://dx.doi.org/10.1136/bmjopen-2021-056059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315896/
https://www.ncbi.nlm.nih.gov/pubmed/35868820
http://dx.doi.org/10.1136/bmjopen-2021-056059

Ejemplares similares